Blue Trust Inc. Buys 888 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Blue Trust Inc. lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 102.4% during the third quarter, Holdings Channel reports. The fund owned 1,755 shares of the company’s stock after acquiring an additional 888 shares during the quarter. Blue Trust Inc.’s holdings in Prestige Consumer Healthcare were worth $121,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Covestor Ltd boosted its holdings in Prestige Consumer Healthcare by 21.6% during the first quarter. Covestor Ltd now owns 834 shares of the company’s stock valued at $61,000 after acquiring an additional 148 shares during the period. Evergreen Capital Management LLC raised its stake in shares of Prestige Consumer Healthcare by 5.4% in the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock valued at $216,000 after buying an additional 160 shares in the last quarter. Miller Howard Investments Inc. NY lifted its holdings in shares of Prestige Consumer Healthcare by 2.2% during the 2nd quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock worth $534,000 after acquiring an additional 165 shares during the period. EverSource Wealth Advisors LLC lifted its stake in Prestige Consumer Healthcare by 80.6% during the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after purchasing an additional 208 shares during the period. Finally, QRG Capital Management Inc. boosted its stake in Prestige Consumer Healthcare by 4.7% in the 2nd quarter. QRG Capital Management Inc. now owns 5,397 shares of the company’s stock valued at $372,000 after buying an additional 242 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $73.64 on Tuesday. Prestige Consumer Healthcare Inc. has a 1 year low of $56.61 and a 1 year high of $75.80. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The firm’s 50 day moving average is $71.82 and its 200-day moving average is $69.39. The firm has a market capitalization of $3.65 billion, a price-to-earnings ratio of 18.00, a PEG ratio of 2.06 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.04. The firm had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare’s revenue was down 4.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.06 EPS. Sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on PBH shares. DA Davidson lifted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.